Medications That Can Cause Chronic Diarrhea
Up to 4% of chronic diarrhea cases are medication-induced, with the most common culprits being magnesium supplements, ACE inhibitors, NSAIDs, DPP-4 inhibitors (gliptins), antineoplastic agents, theophyllines, antibiotics, and antiarrhythmics 1.
Primary Medication Categories
Most Common Offenders
- Magnesium-containing supplements and antacids - osmotic effect
- Antihypertensives - particularly ACE inhibitors and angiotensin receptor blockers (ARBs)
- Olmesartan specifically can cause severe enteropathy with profound diarrhea, weight loss, and dehydration after 1-2 years of use 2
- Irbesartan and valsartan have also been implicated
- NSAIDs - inflammatory mechanisms
- DPP-4 inhibitors (gliptins) - newer antidiabetic agents
- Antibiotics - alter colonic flora (25% of drug-induced diarrhea) 3
Additional High-Risk Medications
- Antineoplastic/chemotherapy agents
- Theophyllines
- Antiarrhythmics
- Prostaglandins
- Colchicine
- Cholinergic agents
- Laxatives (obvious but often overlooked)
- Lactose or sorbitol-containing products
Critical Consideration for Your Patient
In a patient already receiving cholestyramine and rifaximin, paradoxically these medications themselves can contribute to diarrhea:
Rifaximin-Specific Issues
- Can cause C. difficile-associated diarrhea (CDAD) - the FDA label explicitly warns that rifaximin, like nearly all antibacterial agents, can lead to C. difficile overgrowth ranging from mild diarrhea to fatal colitis 4
- This is particularly important since your patient is already on rifaximin
- CDAD can occur up to 2 months after antibiotic administration
Cholestyramine Considerations
- While typically used to treat bile acid diarrhea, it can cause gastrointestinal side effects
- May bind other medications, potentially altering their absorption and effects
Pathophysiologic Mechanisms 3
Drug-induced diarrhea operates through multiple mechanisms, often simultaneously:
- Osmotic diarrhea - magnesium, sorbitol, lactulose
- Secretory diarrhea - prostaglandins, colchicine
- Shortened transit time - prokinetic agents
- Exudative diarrhea/protein-losing enteropathy - NSAIDs, olmesartan
- Malabsorption/maldigestion - acarbose, orlistat
Clinical Approach
Key Historical Features to Elicit
- Temporal relationship: Onset can be immediate or delayed by months to years (olmesartan typically requires 1-2 years of exposure) 2
- Complete medication list: Including over-the-counter products, supplements, and herbal preparations
- Recent medication changes: New additions or dose adjustments
- Severity markers: Fever, blood/mucus in stool, dehydration, weight loss
Critical Pitfall
The time lag between drug initiation and symptom onset can be extremely long - sometimes months to years - making the causal relationship difficult to establish 3. Don't dismiss a medication as causative simply because it was started long ago.
Specific Red Flags
For olmesartan-associated enteropathy 2:
- Caucasian patients >50 years old
- Previously obese/overweight with recent weight loss
- Severe diarrhea with dehydration
- Prolonged olmesartan use (1-2 years)
- Histology may mimic celiac disease
Management Priority
Systematically review and consider discontinuing or substituting any medication from the high-risk categories listed above, starting with the most recent additions and those with the strongest evidence for causing diarrhea. For olmesartan specifically, discontinuation leads to improvement, though healing may take time and some patients require steroids or parenteral nutrition 2.